Rare diseases
Investigational molecules
Locations
Belatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor
AustriaStudy of Belatacept versus Tacrolimus in Kidney Transplant Recipients with Subclinical Antibody Mediated Rejection
FranceStudy of belatacept, tacrolimus and ciclosporin in heart transplant patients at risk of kidney failure
FranceStudy on the Effects of Belatacept, Ciclosporin, and Tacrolimus on Blood Vessel Health in Kidney Transplant Patients
FranceStudy on Switching from Tacrolimus or Ciclosporin to Belatacept for Adolescents with Kidney Transplants
BelgiumStudy on the Safety and Effectiveness of Tacrolimus and Drug Combination for Patients with BK Polyomavirus Infection After Kidney Transplantation
GermanyStudy on Replacing CNIs with Belatacept for Kidney Transplant Patients with Early Graft Dysfunction 3 to 12 Months Post-Transplant
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
